Clinical Trial

3D Mapping Versus Conventional Ablation in AVNRT

Study acronym: MAP-AVNRT
Completed
View on ClinicalTrials.gov →
Summary
This prospective randomized interventional study compared conventional fluoroscopy-guided slow pathway ablation versus three-dimensional electroanatomical mapping-guided ablation in patients with electrophysiologically confirmed typical atrioventricular nodal re-entrant tachycardia (AVNRT). A total of 108 patients were screened for eligibility, of whom 80 eligible patients were randomized in a 1:1 ratio to either conventional fluoroscopic ablation or 3D mapping-guided ablation. Following post-randomization dropouts, the final analysis included 38 patients in the conventional group and 36 patients in the 3D mapping group. The study evaluated fluoroscopy exposure, procedural efficacy, complete slow pathway elimination, procedural success, complications, and arrhythmia recurrence during follow-up.
Trial Details
NCT Number NCT07630480
Lead Sponsor Kafrelsheikh University
Conditions Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia (SVT)
Enrollment 80 participants
Start Date 2023-12-30
Primary Completion 2025-11-23 (estimated)
Study Completion 2025-11-23 (estimated)
Updated on ClinicalTrials.gov 2026-06-05